Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6508
    +0.0008 (+0.13%)
     

  • OIL

    82.66
    -0.15 (-0.18%)
     

  • GOLD

    2,332.30
    -6.10 (-0.26%)
     

  • Bitcoin AUD

    98,655.03
    -3,863.09 (-3.77%)
     

  • CMC Crypto 200

    1,387.48
    -36.62 (-2.57%)
     

  • AUD/EUR

    0.6077
    +0.0006 (+0.10%)
     

  • AUD/NZD

    1.0949
    +0.0007 (+0.07%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,222.13
    +20.86 (+0.12%)
     

  • NIKKEI 225

    37,776.33
    -683.75 (-1.78%)
     

Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist

Alex Carchidi, The Motley Fool
·4-min read
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist

If you're looking to invest $2,500 somewhere it'll grow, but you're a bit leery of buying an increasingly overpriced and hyped-up growth stock like Nvidia, Fulgent Genetics (NASDAQ: FLGT) might be up your alley. Its shares are priced for bargain hunters, and its growth prospects are plentiful. Let's get all the bad news out of the way at once: Fulgent's shares have declined 25% in the past 12 months, and its quarterly revenue fell by 47% in the same period, arriving at $66.1 million in sales for the first quarter of 2023.

Continue reading